Herbert P.
- Country
- Austria
- Department
- Hematology, Oncology and Immunology Department, Stem Cell Transplantation Unit
Research Overview
- Evaluation of Hyperfractionated-Accelerated Radiotherapy and High-Dose Thiotepa Therapy in High-Risk Medulloblastoma Patients Aged Over 3 Years
- Evaluation of Non-Total Body Irradiation Conditioning Regimens with Fludarabine, Thiotepa, and Busulfan in Pediatric Acute Lymphoblastic Leukemia Transplantation
- Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL.
Data & Insights
Has run more than one trial at 58 of 138 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating complex pediatric cancers, with particular emphasis on high-risk medulloblastoma in children over 3 years of age. Their work encompasses innovative therapeutic approaches in pediatric brain tumor management.
- Advanced radiotherapy techniques
- Personalized treatment protocols
- Molecular subgroup classification
Their expertise includes treatment strategies for sonic hedgehog (SHH) subgroup and non-WNT medulloblastoma variants.
Hematologic Malignancies
The investigator focuses on treating acute lymphoblastic leukemia in children and adolescents, with specific expertise in stem cell transplantation procedures and conditioning regimens.
- Allogeneic stem cell transplantation
- Novel conditioning protocols
- HLA-matched donor selection
Their work includes evaluation of total body irradiation alternatives and management of transplant-related complications.
Therapeutic Innovation
The investigator develops and evaluates advanced treatment protocols incorporating hyperfractionated-accelerated radiotherapy and high-dose chemotherapy approaches.
- Radiation therapy optimization
- Maintenance chemotherapy strategies
- Risk-adapted treatment approaches
Their expertise extends to multimodal therapy integration for high-risk pediatric cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.